Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer

OBJECTIVES: To evaluate the protein expression of connexin 43 (Cx43) in primary urothelial bladder cancer and test its association with the histopathological characteristics and clinical outcome. METHODS: A tissue microarray containing 348 tissue samples from 174 patients with primary urothelial car...

Descripción completa

Detalles Bibliográficos
Autores principales: Poyet, Cédric, Buser, Lorenz, Roudnicky, Filip, Detmar, Michael, Hermanns, Thomas, Mannhard, Doris, Höhn, Andrej, Rüschoff, Jan, Zhong, Qing, Sulser, Tullio, Moch, Holger, Wild, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602233/
https://www.ncbi.nlm.nih.gov/pubmed/26251520
http://dx.doi.org/10.1136/jclinpath-2015-202898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602233/
https://www.ncbi.nlm.nih.gov/pubmed/26251520
http://dx.doi.org/10.1136/jclinpath-2015-202898

Ejemplares similares